{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T06:21:52Z","timestamp":1776061312862,"version":"3.50.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"51","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31772742"],"award-info":[{"award-number":["31772742"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong","doi-asserted-by":"publisher","award":["2015A03031103"],"award-info":[{"award-number":["2015A03031103"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.vaccine.2019.09.077","type":"journal-article","created":{"date-parts":[[2019,9,30]],"date-time":"2019-09-30T07:55:59Z","timestamp":1569830159000},"page":"7478-7481","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Artesunate enhances the immune response of rabies vaccine as an adjuvant"],"prefix":"10.1016","volume":"37","author":[{"given":"Jun","family":"Luo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongling","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shile","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2896-3629","authenticated-orcid":false,"given":"Xiaofeng","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.vaccine.2019.09.077_b0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003709","article-title":"Estimating the global burden of endemic canine rabies","volume":"9","author":"Hampson","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"issue":"Suppl","key":"10.1016\/j.vaccine.2019.09.077_b0010","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/S0264-410X(96)00312-X","article-title":"Rabies and rabies research: past, present and future","volume":"15","author":"Fu","year":"1997","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2019.09.077_b0015","first-page":"976","article-title":"The development of new antimalarial drugs: qinghaosu and dihydro-qinghaosu","volume":"112","author":"Tu","year":"1999","journal-title":"Chin Med J (Engl)"},{"issue":"6","key":"10.1016\/j.vaccine.2019.09.077_b0020","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.jinf.2016.02.001","article-title":"UK malaria treatment guidelines 2016","volume":"72","author":"Lalloo","year":"2016","journal-title":"J Infect"},{"issue":"9918","key":"10.1016\/j.vaccine.2019.09.077_b0025","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0140-6736(13)60024-0","article-title":"Malaria","volume":"383","author":"White","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2019.09.077_b0030","series-title":"Guidelines for the Treatment of Malaria","author":"WHO","year":"2015"},{"issue":"3","key":"10.1016\/j.vaccine.2019.09.077_b0035","first-page":"222","article-title":"Artemisinin inhibits proliferation of gallbladder cancer cell lines through triggering cell cycle arrest and apoptosis","volume":"54","author":"Jia","year":"2016","journal-title":"Zhonghua Wai Ke Za Zhi"},{"issue":"1","key":"10.1016\/j.vaccine.2019.09.077_b0040","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1093\/carcin\/bgt277","article-title":"Dihydroartemisinin inhibits the mammalian target of rapamycin-mediated signaling pathways in tumor cells","volume":"35","author":"Odaka","year":"2014","journal-title":"Carcinogenesis"},{"issue":"7","key":"10.1016\/j.vaccine.2019.09.077_b0045","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.arcmed.2018.03.004","article-title":"Inhibitory effect of artesunate on growth and apoptosis of gastric cancer cells","volume":"48","author":"Wang","year":"2017","journal-title":"Arch Med Res"},{"issue":"2","key":"10.1016\/j.vaccine.2019.09.077_b0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0032424","article-title":"SM934 treated lupus-prone NZB x NZW F1 mice by enhancing macrophage interleukin-10 production and suppressing pathogenic T cell development","volume":"7","author":"Hou","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2019.09.077_b0055","article-title":"Artemisinin analogue SM934 ameliorates murine experimental autoimmune encephalomyelitis through enhancing the expansion and functions of regulatory T cell","volume":"2;8(8)","author":"Li","year":"2013","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.vaccine.2019.09.077_b0060","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1006\/clin.1993.1162","article-title":"Artemisinin and its derivatives enhance T lymphocyte-mediated immune responses in normal mice and accelerate immunoreconstitution of mice with syngeneic bone marrow transplantation","volume":"69","author":"Yang","year":"1993","journal-title":"Clin Immunol Immunopathol"},{"issue":"7","key":"10.1016\/j.vaccine.2019.09.077_b0065","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18071600","article-title":"The effects of artemisinin on the cytolytic activity of natural killer (NK) cells","volume":"18","author":"Houh","year":"2017","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10.1016\/j.vaccine.2019.09.077_b0070","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1080\/08923973.2017.1379087","article-title":"Artemisinin therapeutic efficacy in the experimental model of multiple sclerosis","volume":"39","author":"Khakzad","year":"2017","journal-title":"Immunopharmacol Immunotoxicol"},{"issue":"2","key":"10.1016\/j.vaccine.2019.09.077_b0075","article-title":"A recombinant rabies virus encoding two copies of the glycoprotein gene confers protection in dogs against a virulent challenge","volume":"9","author":"Liu","year":"2014","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.vaccine.2019.09.077_b0080","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0022-1759(97)00212-3","article-title":"Development of a fluorescent antibody virus neutralisation test (FAVN test) for the quantitation of rabies-neutralising antibody","volume":"212","author":"Cliquet","year":"1998","journal-title":"J Immunol Methods"},{"issue":"3","key":"10.1016\/j.vaccine.2019.09.077_b0085","doi-asserted-by":"crossref","DOI":"10.3390\/jcm6030030","article-title":"Novel Pharmacological activity of artesunate and artemisinin: their potential as anti-tubercular agents","volume":"6","author":"Choi","year":"2017","journal-title":"J Clin Med"},{"issue":"2","key":"10.1016\/j.vaccine.2019.09.077_b0090","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s00436-011-2474-5","article-title":"Effects of artemether, artesunate and dihydroartemisinin administered orally at multiple doses or combination in treatment of mice infected with Schistosoma japonicum","volume":"109","author":"Li","year":"2011","journal-title":"Parasitol Res"},{"issue":"5","key":"10.1016\/j.vaccine.2019.09.077_b0095","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1007\/s00436-011-2692-x","article-title":"Effect of the in vivo activity of dihydroartemisinin against Schistosoma mansoni infection in mice","volume":"110","author":"Li","year":"2012","journal-title":"Parasitol Res"},{"key":"10.1016\/j.vaccine.2019.09.077_b0100","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.vetpar.2016.12.008","article-title":"Artesunate-tafenoquine combination therapy promotes clearance and abrogates transmission of the avian malaria parasite plasmodium gallinaceum","volume":"233","author":"Tasai","year":"2017","journal-title":"Vet Parasitol"},{"issue":"8","key":"10.1016\/j.vaccine.2019.09.077_b0105","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/j.1348-0421.2011.00354.x","article-title":"A unique transcription mode of rabies virus high egg passage-Flury strain detected in infected baby hamster kidney-21 cells","volume":"55","author":"Morimoto","year":"2011","journal-title":"Microbiol Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2019.09.077_b0110","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1007\/s13337-015-0285-5","article-title":"Molecular and immunogenic characterization of BHK-21 cell line adapted CVS-11 strain of rabies virus and future prospect in vaccination strategy","volume":"26","author":"Patel","year":"2015","journal-title":"Virusdisease"},{"issue":"7","key":"10.1016\/j.vaccine.2019.09.077_b0115","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.1128\/JVI.76.7.3374-3381.2002","article-title":"Overexpression of the rabies virus glycoprotein results in enhancement of apoptosis and antiviral immune response","volume":"76","author":"Faber","year":"2002","journal-title":"J Virol"},{"issue":"3","key":"10.1016\/j.vaccine.2019.09.077_b0120","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1348-0421.2006.tb03785.x","article-title":"Characterization of recombinant rabies virus carrying double glycoprotein genes","volume":"50","author":"Hosokawa-Muto","year":"2006","journal-title":"Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2019.09.077_b0125","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1186\/1743-422X-8-454","article-title":"Generation of a recombinant rabies Flury LEP virus carrying an additional G gene creates an improved seed virus for inactivated vaccine production","volume":"8","author":"Tao","year":"2011","journal-title":"Virol J"},{"issue":"1","key":"10.1016\/j.vaccine.2019.09.077_b0130","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.cellimm.2011.06.008","article-title":"Dihydroartemisinin shift the immune response towards Th1, inhibit the tumor growth in vitro and in vivo","volume":"271","author":"Noori","year":"2011","journal-title":"Cell Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2019.09.077_b0135","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1007\/s12272-014-0491-5","article-title":"Artesunate inhibits proliferation of naive CD4(+) T cells but enhances function of effector T cells","volume":"38","author":"Lee","year":"2015","journal-title":"Arch Pharm Res"},{"issue":"9","key":"10.1016\/j.vaccine.2019.09.077_b0140","first-page":"526","article-title":"Therapeutic potential of artesunate in experimental autoimmune myasthenia gravis by upregulated T regulatory cells and regulation of Th1\/Th2 cytokines","volume":"73","author":"Meng","year":"2018","journal-title":"Pharmazie"},{"issue":"36","key":"10.1016\/j.vaccine.2019.09.077_b0145","doi-asserted-by":"crossref","first-page":"4644","DOI":"10.1016\/j.vaccine.2014.06.058","article-title":"A recombinant rabies vaccine expressing the trimeric form of the glycoprotein confers enhanced immunogenicity and protection in outbred mice","volume":"32","author":"Koraka","year":"2014","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19313052?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19313052?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,11,20]],"date-time":"2019-11-20T17:36:29Z","timestamp":1574271389000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19313052"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":29,"journal-issue":{"issue":"51","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["S0264410X19313052"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.09.077","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Artesunate enhances the immune response of rabies vaccine as an adjuvant","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.09.077","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}